Luba Greenwood JD

Luba Greenwood JD General Information

Biography

Ms. Luba Greenwood serves as Chair of its Board of Directors at Closed Loop Medicine. She is a Co-Founder and serves as Board Member at Luca Biologics. She serves as a Board Observer at Stalicla. She serves as an Advisor at Catalyst Health Ventures. She served as Chief Executive Officer & Chairman at Kojin Therapeutics. She serves as an Advisor at VLX Ventures and Quris AI. She serves as a Board Member at Matchpoint Therapeutics. She served as a Board Member at Stalicla. She serves as a Board Member at BenchSci. She serves as a Managing Partner at Binney Street Capital and Cathy Capital. She also served as a Board Member at Kojin Therapeutics. She has also served as a Senior Advisor at Grove Ventures. She served as an Executive Advisor at GrayBella Capital. She served as Vice President of global Mergers & Acquisitions, and Business Development at F. Hoffmann-La Roche. She served as Senior Counsel for Mergers and Acquisitions and Corporate Compliance at Pfizer. She began her career as a litigator at a leading national law firm, Wilmer Cutler Pickering Hale and Dorr. She is a recipient of several awards and honors for her work in the community, including the Science Club for Girls Catalyst Award for her commitment to advocating for women in science and technology, and has served as a non-profit board member of Longwood Symphony Orchestra and executive coach for MassNextGen.She is a veteran biotech and tech investor and company builder, having recently served as an executive at Google Life Sciences (Verily) and as Vice President of Global Business Development and Mergers and acquisitions at Roche, where she also established and led the East Coast Innovation Hub for the Diagnostics Division. She serves as a Senior Advisor to the CEO of the Dana-Farber Cancer Institute and lectures at Harvard University in the School of Engineering and Applied Sciences. She serves on numerous boards, including the Massachusetts Biotechnology Council (MassBio) and Brooklyn ImmunoTherapeutics, is a Thought Leader for the New England Journal of Medicine (NEJM) Catalyst, and is a Founder of the Pharma Digital Health Roundtable. She serves as Board Advisor at Intrinsic Bioscience.